News
Bristol-Myers Squibb sees stabilizing sales, growth in key drugs, and raised guidance. Click to read more about why BMY is an ...
(Reuters) -Bristol Myers Squibb posted much better-than-expected second-quarter results on Thursday on strong sales of its ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
Looking ahead, revenue is expected to decline by 5.5% p.a. on average during the next 3 years, while revenues in the ...
A multinational biopharmaceutical corporation, Bristol-Myers Squibb Company (NYSE:BMY) is engaged in product discovery, ...
Myers Squibb (NYSE:BMY) shares inched up on Friday after six consecutive sessions of fall. The stock was up 2.2% at $44.24.
18h
TipRanks on MSNBristol-Myers Squibb’s Earnings Call Highlights Growth and ChallengesBristol-Myers Squibb Company (($BMY)) has held its Q2 earnings call. Read on for the main highlights of the call. Bristol-Myers Squibb’s recent ...
Pfizer CEO Albert Bourla is expected to attend a $25 million fundraiser at US President Donald Trump’s golf club in ...
The president threatened to “deploy every tool” in the administration’s arsenal if drug companies don’t cut certain prices by ...
Health care stocks sank after the White House released letters asking big pharmaceutical companies to cut prices and make other changes in the next 60 days. Eli Lilly & Co. fell 2.6%, UnitedHealth ...
Bristol Myers Squibb Co. research and ratings by Barron's. View BMY revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results